Serologic tests are not helpful in managing inflammatory bowel disease

被引：7

作者：

Present, DH ^{[1
]}

机构：

[1] Mt Sinai Med Ctr, Dept Med, Div Gastroenterol, New York, NY 10029 USA

来源：

INFLAMMATORY BOWEL DISEASES | 2002年 / 8卷 / 03期

关键词：

D O I：

10.1097/00054725-200205000-00013

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

In summary, although our scientific knowledge has been enhanced, none of these studies are required to properly administer 6-MP. An experienced clinician monitoring the CBC and liver function studies will suffice.

引用

页码：227 / 229

页数：3

共 8 条

[1]

ABREU MT, 2001, CLIN PERSPECT GASTRO, V4, P155

[2] Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease [J].

Cuffari, C ;

Hunt, S ;

Bayless, T .

GUT, 2001, 48 (05) :642-646

[3] Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease [J].

Dubinsky, MC ;

Lamothe, S ;

Yang, HY ;

Targan, SR ;

Sinnett, D ;

Théorêt, Y ;

Seidman, EG .

GASTROENTEROLOGY, 2000, 118 (04) :705-713

[4] An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy [J].

Dubinsky, MC ;

Hassard, PV ;

Seidman, EG ;

Kam, LY ;

Abreu, MT ;

Targan, SR ;

Vasiliauskas, EA .

INFLAMMATORY BOWEL DISEASES, 2001, 7 (03) :181-189

[5] High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis [J].

Fleshner, PR ;

Vasiliauskas, EA ;

Kam, LY ;

Fleshner, NE ;

Gaiennie, J ;

Abreu-Martin, MT ;

Targan, SR .

GUT, 2001, 49 (05) :671-677

[6] Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease [J].

Lowry, PW ;

Franklin, CL ;

Weaver, AL ;

Pike, MG ;

Mays, DC ;

Tremaine, WJ ;

Lipsky, JJ ;

Sandborn, WJ .

GUT, 2001, 49 (05) :665-670

[7] Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease [J].

Rutgeerts, P ;

Vermeire, S .

GASTROENTEROLOGY, 1998, 115 (04) :1006-1009

[8] Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease [J].

Sandborn, WJ ;

Loftus, EV ;

Colombel, JF ;

Fleming, KA ;

Seibold, F ;

Homburger, HA ;

Sendid, T ;

Chapman, RW ;

Tremaine, WJ ;

Kaul, DK ;

Wallace, J ;

Harmsen, WS ;

Zinsmeister, AR ;

Targan, SR .

INFLAMMATORY BOWEL DISEASES, 2001, 7 (03) :192-201

← 1 →